,Set,NGenes,Direction,PValue,FDR
1,WP_COMPLEMENT_ACTIVATION,11,Down,7.60221673695323e-05,0.0627182880798641
2,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.000177736211953952,0.073316187431005
3,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.000344013973005748,0.0946038425765806
4,WP_PROSTAGLANDIN_SIGNALING,24,Up,0.00067473639613407,0.123234569759262
5,WP_TYPE_II_INTERFERON_SIGNALING,31,Up,0.000746876180359162,0.123234569759262
6,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.000899658924561415,0.123703102127195
7,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.00139158276249093,0.164007968436431
8,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Up,0.00173511190948135,0.178933415665264
9,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Up,0.00273853094886492,0.242360059752834
10,WP_CCL18_SIGNALING,23,Up,0.00293769769397375,0.242360059752834
11,WP_MATRIX_METALLOPROTEINASES,10,Up,0.00397401735860681,0.298051301895511
12,WP_PEPTIDE_GPCRS,14,Up,0.00480139757169668,0.313916487890668
13,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.00494656283948931,0.313916487890668
14,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.00564247447618755,0.324721029391942
15,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.00590401871621712,0.324721029391942
16,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Up,0.00651436037479741,0.335633444342303
17,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Up,0.00750149483424347,0.335633444342303
18,WP_ENDOTHELIN_PATHWAYS,12,Up,0.00761291570727775,0.335633444342303
19,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Up,0.00772973993030758,0.335633444342303
20,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.00848218272828649,0.349890037541818
21,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.0119373424336504,0.449656086288042
22,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0138793544079145,0.449656086288042
23,WP_PRION_DISEASE_PATHWAY,29,Up,0.0146254598390412,0.449656086288042
24,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.0152406177513058,0.449656086288042
25,WP_PPAR_SIGNALING,37,Down,0.0162698576095267,0.449656086288042
26,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.0164355760988774,0.449656086288042
27,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.0169740254581938,0.449656086288042
28,WP_ESTROGEN_METABOLISM_WP5276,9,Down,0.0205037657134403,0.449656086288042
29,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Up,0.0208225309093225,0.449656086288042
30,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0209533933097521,0.449656086288042
31,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.0214733503823809,0.449656086288042
32,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Up,0.0218158885023561,0.449656086288042
33,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Up,0.0228225170789855,0.449656086288042
34,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.0231119696080825,0.449656086288042
35,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.0232935557390259,0.449656086288042
36,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Up,0.0232948379433794,0.449656086288042
37,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.0233290925029536,0.449656086288042
38,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.0235859074253498,0.449656086288042
39,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.0236841460943338,0.449656086288042
40,WP_VITAMIN_B12_DISORDERS,9,Up,0.0238012896470727,0.449656086288042
41,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.0243211691632453,0.449656086288042
42,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.0245808542279742,0.449656086288042
43,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Up,0.0256766599767069,0.449656086288042
44,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.0264395622416483,0.449656086288042
45,WP_FOCAL_ADHESION,117,Up,0.0270509446320796,0.449656086288042
46,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Up,0.0272177058096106,0.449656086288042
47,WP_KLEEFSTRA_SYNDROME,25,Down,0.0277677201033739,0.449656086288042
48,WP_BLADDER_CANCER,30,Up,0.0278866249673821,0.449656086288042
49,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.0281430653141516,0.449656086288042
50,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Up,0.0286078750976121,0.449656086288042
51,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.0288567832744764,0.449656086288042
52,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Up,0.0291314421860143,0.449656086288042
53,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.0294000310145581,0.449656086288042
54,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.0294320347388536,0.449656086288042
55,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.0304644087975473,0.451041639179054
56,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.0324575775341329,0.451041639179054
57,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.0324575775341329,0.451041639179054
58,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.032631988345013,0.451041639179054
59,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.0331872275767389,0.451041639179054
60,WP_POSTCOVID_NEUROINFLAMMATION,13,Up,0.0333167616788837,0.451041639179054
61,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.0336430119750744,0.451041639179054
62,WP_LUNG_FIBROSIS,35,Up,0.03395319527458,0.451041639179054
63,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.0348441293837686,0.451041639179054
64,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.0349898968575266,0.451041639179054
65,WP_PURINERGIC_SIGNALING,16,Up,0.0356499292090071,0.452479870729705
66,WP_MELANOMA,53,Up,0.0371796286843967,0.464745358554959
67,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.0386287969532686,0.475653096812635
68,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Up,0.04226105848001,0.489938108708455
69,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.0423168283384379,0.489938108708455
70,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Up,0.0430693884638539,0.489938108708455
71,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.0434973920448464,0.489938108708455
72,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Up,0.0437584081333296,0.489938108708455
73,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.0447813851629387,0.489938108708455
74,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0448876875000444,0.489938108708455
75,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.0450657391328527,0.489938108708455
76,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.0451336924385971,0.489938108708455
77,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.0462707799480906,0.492374061156801
78,WP_GASTRIC_CANCER_NETWORK_1,16,Down,0.0474157729928125,0.492374061156801
79,WP_NUCLEOTIDE_GPCRS,7,Up,0.0478312744422669,0.492374061156801
80,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.0482350881654044,0.492374061156801
81,WP_TAMOXIFEN_METABOLISM,3,Down,0.048987852953209,0.492374061156801
82,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.049714565208774,0.492374061156801
83,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.0509179441862977,0.492374061156801
84,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Up,0.0510062550371997,0.492374061156801
85,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.0514554132095578,0.492374061156801
86,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.0514672183145709,0.492374061156801
87,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.051923082812899,0.492374061156801
88,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0558324305923804,0.512674538750947
89,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.0564913522976386,0.512674538750947
90,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.0565562642121321,0.512674538750947
91,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.0567584959412181,0.512674538750947
92,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.0578471934313688,0.512674538750947
93,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.0589353397480991,0.512674538750947
94,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.0596250273251479,0.512674538750947
95,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Down,0.0598429848279995,0.512674538750947
96,WP_MEVALONATE_PATHWAY,7,Up,0.0605448255525473,0.512674538750947
97,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.0607066272975187,0.512674538750947
98,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Up,0.0608995209667791,0.512674538750947
99,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.0616828557724761,0.514023798103967
100,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.0635251096110077,0.524082154290814
101,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.0645986643380308,0.527662357216588
102,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.0711751954556416,0.556171014390156
103,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.071521627959436,0.556171014390156
104,WP_ECTODERM_DIFFERENTIATION,72,Up,0.0720836095547424,0.556171014390156
105,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0730693759012234,0.556171014390156
106,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.0733020594680152,0.556171014390156
107,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Up,0.0736455429487749,0.556171014390156
108,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.0742211409397062,0.556171014390156
109,WP_SMALL_LIGAND_GPCRS,7,Up,0.0742866562162332,0.556171014390156
110,WP_NEOVASCULARIZATION_PROCESSES,23,Up,0.0752822655553236,0.556171014390156
111,WP_IL26_SIGNALING,33,Up,0.0753855178357495,0.556171014390156
112,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Up,0.0755044286202394,0.556171014390156
113,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.0779955569304918,0.569436588209343
114,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.0797121490395003,0.576864236470068
115,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Up,0.0842525885023708,0.604420743603965
116,WP_BURN_WOUND_HEALING,62,Up,0.0855796028725623,0.60864803767124
117,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Up,0.0889122158778464,0.610396346517633
118,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.0896936385379425,0.610396346517633
119,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Up,0.0900782317702376,0.610396346517633
120,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.0905739980276937,0.610396346517633
121,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.0908843270732512,0.610396346517633
122,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Up,0.0909253878463188,0.610396346517633
123,WP_OSTEOBLAST_SIGNALING,3,Up,0.0910045462080834,0.610396346517633
124,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.0937262499675756,0.612681741584945
125,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.0939158556758047,0.612681741584945
126,WP_LUNG_PATHOLOGY_OF_COVID19,16,Up,0.0943059529745146,0.612681741584945
127,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.0970112389006913,0.612681741584945
128,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.0970112389006913,0.612681741584945
129,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.0970487535787491,0.612681741584945
130,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.0983412809939667,0.612681741584945
131,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.0985346513462636,0.612681741584945
132,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.0985346513462636,0.612681741584945
133,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.0994466454544667,0.612681741584945
134,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.100188807298612,0.612681741584945
135,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.100257012259355,0.612681741584945
136,WP_STEROID_BIOSYNTHESIS,2,Down,0.101308035534986,0.614552421443846
137,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.103513883117969,0.622766846845168
138,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.104171908926828,0.622766846845168
139,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.105706036181074,0.62443401845453
140,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.106678989830153,0.62443401845453
141,WP_ZINC_HOMEOSTASIS,20,Up,0.107305094672119,0.62443401845453
142,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Up,0.107478340146113,0.62443401845453
143,WP_NRXN1_DELETION_SYNDROME,2,Down,0.108436499884511,0.625595191641407
144,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Up,0.109767498857087,0.628876295535392
145,WP_INTERFERONMEDIATED_SIGNALING,14,Up,0.111315826157931,0.629638283688597
146,WP_ENDOMETRIAL_CANCER,48,Up,0.111463978711701,0.629638283688597
147,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,0.115341920428538,0.629638283688597
148,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Up,0.116529683370703,0.629638283688597
149,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.116665341141424,0.629638283688597
150,WP_HEPATITIS_B_INFECTION,118,Up,0.116816805600053,0.629638283688597
151,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.117125587349011,0.629638283688597
152,WP_NOTCH_SIGNALING_WP61,49,Up,0.117913863653969,0.629638283688597
153,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.119181032058734,0.629638283688597
154,WP_OSTEOPONTIN_SIGNALING,12,Up,0.11931668052677,0.629638283688597
155,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.119629544491085,0.629638283688597
156,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Up,0.120514364997507,0.629638283688597
157,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.121716136398006,0.629638283688597
158,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Up,0.123448942605356,0.629638283688597
159,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.123818010954984,0.629638283688597
160,WP_MEASLES_VIRUS_INFECTION,99,Up,0.123888480677751,0.629638283688597
161,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.123919573672093,0.629638283688597
162,WP_CHEMOKINE_SIGNALING,115,Up,0.124195439835579,0.629638283688597
163,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.124401260898474,0.629638283688597
164,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.128041976003879,0.640576781795553
165,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.128840267668807,0.640576781795553
166,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.128948816150937,0.640576781795553
167,WP_SEROTONIN_AND_ANXIETY,6,Up,0.130122183465984,0.640576781795553
168,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.130813498219392,0.640576781795553
169,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.131221183179938,0.640576781795553
170,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.13598527042924,0.655980168413297
171,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.136459627411718,0.655980168413297
172,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.136761926020712,0.655980168413297
173,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.138374821490955,0.659879929075364
174,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.141126530482309,0.667764401165621
175,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Up,0.141646994186647,0.667764401165621
176,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.142733454079561,0.66906306599794
177,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Up,0.146223357823703,0.678872935008659
178,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.146471978704898,0.678872935008659
179,WP_NUCLEAR_RECEPTORS,21,Down,0.148044748320655,0.681122380757433
180,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.150716228685837,0.681122380757433
181,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.151170301747852,0.681122380757433
182,WP_SULINDAC_METABOLIC_PATHWAY,3,Down,0.152337328764652,0.681122380757433
183,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.152681558050656,0.681122380757433
184,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.152915526791926,0.681122380757433
185,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.154209128782944,0.681122380757433
186,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.154845901156995,0.681122380757433
187,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.155299192453868,0.681122380757433
188,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Up,0.15545641905152,0.681122380757433
189,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.156098317935859,0.681122380757433
190,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.158031254187092,0.681122380757433
191,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.1593119272305,0.681122380757433
192,WP_NAD_METABOLISM,11,Down,0.159895603927604,0.681122380757433
193,WP_KREBS_CYCLE_DISORDERS,11,Down,0.159911668876093,0.681122380757433
194,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Up,0.161171031309041,0.681122380757433
195,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.16153274601132,0.681122380757433
196,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.161818165610251,0.681122380757433
197,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.164589072457414,0.689268958260745
198,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.167012196383215,0.69588415159673
199,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.16815341917322,0.697118446321138
200,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Up,0.169627582547299,0.699713778007609
201,WP_MACROPHAGE_MARKERS,8,Down,0.172814735826395,0.70154031149178
202,WP_RETINOL_METABOLISM,5,Up,0.173119837664064,0.70154031149178
203,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.173395001346339,0.70154031149178
204,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.173471786114331,0.70154031149178
205,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.175212645097227,0.704496893883496
206,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Up,0.175910739563637,0.704496893883496
207,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.181816871342003,0.722918228209355
208,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.18436420380856,0.722918228209355
209,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.184389214307688,0.722918228209355
210,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.184470029152176,0.722918228209355
211,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.184891813517787,0.722918228209355
212,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,39,Up,0.189466700576414,0.737311452714817
213,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.190504529864584,0.737869657926205
214,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.193210741361358,0.744854493565981
215,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.195426572120155,0.748088938550478
216,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.196287183608245,0.748088938550478
217,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.19677006020055,0.748088938550478
218,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.198881193268319,0.752646717643869
219,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Up,0.201595294185878,0.759434327412556
220,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.203748235680768,0.76405588380288
221,WP_BENZOAPYRENE_METABOLISM,4,Down,0.209152740757259,0.777544689125828
222,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.209230207255677,0.777544689125828
223,WP_SPINAL_CORD_INJURY,65,Up,0.21039955534716,0.778384005208102
224,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.211619227840023,0.779401173964371
225,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.217437850770029,0.786111542675133
226,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.217525289796131,0.786111542675133
227,WP_IRINOTECAN_PATHWAY,5,Down,0.218564538152665,0.786111542675133
228,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,81,Down,0.221059630933743,0.786111542675133
229,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.222456128933908,0.786111542675133
230,WP_SMALL_CELL_LUNG_CANCER,64,Up,0.225697467440819,0.786111542675133
231,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.225866889840026,0.786111542675133
232,WP_VEGFAVEGFR2_SIGNALING,338,Up,0.2266923906767,0.786111542675133
233,WP_DRAVET_SYNDROME,12,Up,0.2272036854349,0.786111542675133
234,WP_GPR40_PATHWAY,7,Down,0.228332235535183,0.786111542675133
235,WP_AGERAGE_PATHWAY,55,Up,0.22959673968594,0.786111542675133
236,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.229938202266275,0.786111542675133
237,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.230070792464998,0.786111542675133
238,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.232017461656357,0.786111542675133
239,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.232719075915503,0.786111542675133
240,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.232978329985536,0.786111542675133
241,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.236335876102495,0.786111542675133
242,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.236644603769254,0.786111542675133
243,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.23702867508092,0.786111542675133
244,WP_PROTEASOME_DEGRADATION,57,Up,0.237245545358423,0.786111542675133
245,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.238099789034003,0.786111542675133
246,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.238344833952262,0.786111542675133
247,WP_HEART_DEVELOPMENT,15,Up,0.238516765699423,0.786111542675133
248,WP_APOPTOSIS,69,Up,0.239176424615677,0.786111542675133
249,WP_SERINE_METABOLISM,7,Up,0.239637593911671,0.786111542675133
250,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.240487476769138,0.786111542675133
251,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.240775166963696,0.786111542675133
252,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Up,0.241189616861114,0.786111542675133
253,WP_GASTRIN_SIGNALING,91,Up,0.24222134457004,0.786111542675133
254,WP_METHYLATION_PATHWAYS,5,Up,0.242903071189894,0.786111542675133
255,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.242979931372314,0.786111542675133
256,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.247957854155041,0.792111789217531
257,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.247957854155041,0.792111789217531
258,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.248757019782284,0.792111789217531
259,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.249618270722822,0.792111789217531
260,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.249635230541282,0.792111789217531
261,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.250950758488863,0.793235156142957
262,WP_HUNGER_AND_SATIETY,2,Down,0.253259605848787,0.793244037671865
263,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.25329434367982,0.793244037671865
264,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.254276252868177,0.793244037671865
265,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.254799599979448,0.793244037671865
266,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.25847557569065,0.798855729465923
267,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Up,0.259102435288046,0.798855729465923
268,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,6,Down,0.261006029391778,0.798855729465923
269,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.261443595975673,0.798855729465923
270,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.261722631905384,0.798855729465923
271,WP_NRF2_PATHWAY,69,Up,0.262465928271383,0.798855729465923
272,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.263380313229977,0.798855729465923
273,WP_PI3KAKT_SIGNALING,175,Up,0.26702886279546,0.80265612175108
274,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.267189098596115,0.80265612175108
275,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Up,0.267552040583693,0.80265612175108
276,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.273521749090764,0.803391586183271
277,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.273955286055119,0.803391586183271
278,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.274427062655735,0.803391586183271
279,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.274437070370993,0.803391586183271
280,WP_TGFB_SMAD_SIGNALING,6,Up,0.274592149544185,0.803391586183271
281,WP_NPHP1_DELETION_SYNDROME,10,Down,0.276018545302893,0.803391586183271
282,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.277064538052022,0.803391586183271
283,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.277712080138863,0.803391586183271
284,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.279904541109487,0.803391586183271
285,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.28060368787905,0.803391586183271
286,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.280783715134552,0.803391586183271
287,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.281630657546705,0.803391586183271
288,WP_IL17_SIGNALING,24,Up,0.28222780957873,0.803391586183271
289,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.282996051948429,0.803391586183271
290,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.283204913125863,0.803391586183271
291,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.284183250617075,0.803391586183271
292,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.284351931109715,0.803391586183271
293,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Up,0.288103984011288,0.809922861451567
294,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.289336182208216,0.809922861451567
295,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.292408667346722,0.809922861451567
296,WP_COPPER_HOMEOSTASIS,39,Up,0.292520767340803,0.809922861451567
297,WP_IL7_SIGNALING,24,Up,0.292700174949497,0.809922861451567
298,WP_BREAST_CANCER_PATHWAY,83,Up,0.293051551224444,0.809922861451567
299,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.295354899557202,0.809922861451567
300,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.295387138087853,0.809922861451567
301,WP_CANCER_PATHWAYS,294,Up,0.295499128844753,0.809922861451567
302,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.298442144831692,0.811033436747876
303,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.298677555341861,0.811033436747876
304,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.302373742321786,0.811033436747876
305,WP_PYRIMIDINE_METABOLISM,70,Up,0.3059910209882,0.811033436747876
306,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Up,0.306940430787731,0.811033436747876
307,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.308116296464723,0.811033436747876
308,WP_JOUBERT_SYNDROME,66,Down,0.311014187377496,0.811033436747876
309,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.312141205159707,0.811033436747876
310,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.314227645676833,0.811033436747876
311,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.315662413339581,0.811033436747876
312,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Up,0.315687623638022,0.811033436747876
313,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.317462691193523,0.811033436747876
314,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.317676388948049,0.811033436747876
315,WP_OSTEOCLAST_SIGNALING,9,Up,0.321906521508769,0.811033436747876
316,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.322024949234948,0.811033436747876
317,WP_ATM_SIGNALING,33,Down,0.323592114438107,0.811033436747876
318,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Down,0.323769230389732,0.811033436747876
319,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Up,0.324855902187298,0.811033436747876
320,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.325800339570666,0.811033436747876
321,WP_CELL_CYCLE,88,Up,0.325901464162369,0.811033436747876
322,WP_TRANSLATION_FACTORS,49,Down,0.32929642898778,0.811033436747876
323,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.330815745178348,0.811033436747876
324,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Up,0.331469700441915,0.811033436747876
325,WP_SLEEP_REGULATION,10,Down,0.332331364644568,0.811033436747876
326,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.332544898691943,0.811033436747876
327,WP_CAMKK2_PATHWAY,29,Up,0.332564427304506,0.811033436747876
328,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.332630731226682,0.811033436747876
329,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.333148304884094,0.811033436747876
330,WP_RAC1PAK1P38MMP2_PATHWAY,52,Up,0.333884340265048,0.811033436747876
331,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Up,0.334027158504107,0.811033436747876
332,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.335520192221522,0.811033436747876
333,WP_TAR_SYNDROME,45,Up,0.335880395354216,0.811033436747876
334,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.337722207013918,0.811033436747876
335,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.338169369535073,0.811033436747876
336,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.338386016745114,0.811033436747876
337,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.338576220401567,0.811033436747876
338,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.338919847134016,0.811033436747876
339,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.33988441582111,0.811033436747876
340,WP_PLEURAL_MESOTHELIOMA,247,Up,0.340400586342931,0.811033436747876
341,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.341293406892096,0.811033436747876
342,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.345250687935536,0.811033436747876
343,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.347382346377436,0.811033436747876
344,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.347869955825416,0.811033436747876
345,WP_WNT_SIGNALING_WP363,40,Up,0.348310027390454,0.811033436747876
346,WP_FOXA2_PATHWAY,9,Down,0.350521679018686,0.811033436747876
347,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.351425661471526,0.811033436747876
348,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.352772174713675,0.811033436747876
349,WP_IL19_SIGNALING,20,Up,0.353279430466921,0.811033436747876
350,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.353334685948797,0.811033436747876
351,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.354366196928771,0.811033436747876
352,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.355033561830852,0.811033436747876
353,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.355529218731428,0.811033436747876
354,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.35554781157751,0.811033436747876
355,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,94,Up,0.355713113423617,0.811033436747876
356,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Up,0.356362677878088,0.811033436747876
357,WP_ALZHEIMERS_DISEASE,183,Up,0.356713448746331,0.811033436747876
358,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.356713448746331,0.811033436747876
359,WP_ANGIOGENESIS,14,Up,0.356915692137001,0.811033436747876
360,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.357504167851837,0.811033436747876
361,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.357712504402965,0.811033436747876
362,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.358480874488752,0.811033436747876
363,WP_HEME_BIOSYNTHESIS,8,Up,0.358480874488752,0.811033436747876
364,WP_GLUTATHIONE_METABOLISM,10,Up,0.359090900232473,0.811033436747876
365,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.360501787440503,0.811033436747876
366,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.361075651548545,0.811033436747876
367,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.362366958815508,0.811033436747876
368,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.362557505886857,0.811033436747876
369,WP_IL5_SIGNALING,37,Up,0.362753137163595,0.811033436747876
370,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.365411980057274,0.814582755678791
371,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.366425433064045,0.814582755678791
372,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Up,0.367302769833346,0.814582755678791
373,WP_TYPE_III_INTERFERON_SIGNALING,6,Up,0.368532928196434,0.815119747351363
374,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Up,0.372296317636669,0.82124187713971
375,WP_VITAMIN_B12_METABOLISM,24,Up,0.375195430188343,0.823541628409917
376,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.37533533609955,0.823541628409917
377,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.377589969543687,0.826291047409926
378,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Up,0.38071919624413,0.828876454211967
379,WP_DNA_DAMAGE_RESPONSE,57,Up,0.380780819571316,0.828876454211967
380,WP_SPHINGOLIPID_PATHWAY,21,Up,0.38191202558055,0.829151108168299
381,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Up,0.384672058538885,0.832951307859789
382,WP_10Q22Q23_COPY_NUMBER_VARIATION,25,Up,0.387070922083601,0.834940108836443
383,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.387833207539865,0.834940108836443
384,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.389363117417653,0.834940108836443
385,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Down,0.39009066121143,0.834940108836443
386,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.392089282616588,0.834940108836443
387,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.39216613633144,0.834940108836443
388,WP_DNA_REPLICATION,34,Up,0.392674863307321,0.834940108836443
389,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Up,0.394840489572467,0.836085534046731
390,WP_PDGF_PATHWAY,36,Up,0.396743341395381,0.836085534046731
391,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.396837745963613,0.836085534046731
392,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Up,0.397375662473019,0.836085534046731
393,WP_MAPK_SIGNALING,157,Up,0.398571153807188,0.836085534046731
394,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.400919219382504,0.836085534046731
395,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.400993839445525,0.836085534046731
396,WP_INSULIN_SIGNALING,127,Down,0.401321056342431,0.836085534046731
397,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.402514443437172,0.836459485732158
398,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.404508883755918,0.837609066130249
399,WP_BDNFTRKB_SIGNALING,26,Down,0.405098202892084,0.837609066130249
400,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.406710481633878,0.838840368369874
401,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.409349102909213,0.841280019775115
402,WP_EICOSANOID_SYNTHESIS,13,Down,0.410574866853433,0.841280019775115
403,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.41148454585097,0.841280019775115
404,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.412941714745483,0.841280019775115
405,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.413247624634941,0.841280019775115
406,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.414011743065087,0.841280019775115
407,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.41554948869693,0.842330044655939
408,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.418913457709339,0.847067653456384
409,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.42311405302475,0.851294180669664
410,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Up,0.423372547671007,0.851294180669664
411,WP_ADIPOGENESIS,80,Up,0.425734350544846,0.851294180669664
412,WP_NUCLEAR_RECEPTORS_METAPATHWAY,176,Up,0.427122182424499,0.851294180669664
413,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.427718896513203,0.851294180669664
414,WP_PDGFRBETA_PATHWAY,27,Up,0.429143349935299,0.851294180669664
415,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.431980869061452,0.851294180669664
416,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.432230912112278,0.851294180669664
417,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.432599084773245,0.851294180669664
418,WP_MONOAMINE_TRANSPORT,11,Up,0.433392431624293,0.851294180669664
419,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.435446955739959,0.851294180669664
420,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.436504168275823,0.851294180669664
421,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.436727522108687,0.851294180669664
422,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.439364393662519,0.851294180669664
423,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.440329744639388,0.851294180669664
424,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Up,0.442386410725754,0.851294180669664
425,WP_IL2_SIGNALING,37,Up,0.443498837708933,0.851294180669664
426,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.443955750224161,0.851294180669664
427,WP_WNT_SIGNALING_WP428,59,Up,0.444378001931078,0.851294180669664
428,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.445211903402682,0.851294180669664
429,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Up,0.447052839055357,0.851294180669664
430,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.448327518415392,0.851294180669664
431,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.449158971150271,0.851294180669664
432,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.449619727234674,0.851294180669664
433,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.450288392156435,0.851294180669664
434,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.45044986622827,0.851294180669664
435,WP_ENDODERM_DIFFERENTIATION,82,Up,0.450596820726623,0.851294180669664
436,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Down,0.450674158399802,0.851294180669664
437,WP_CILIOPATHIES,116,Down,0.450927947821386,0.851294180669664
438,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.453320081808989,0.851530683533767
439,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.453529415765056,0.851530683533767
440,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.454493625576154,0.851530683533767
441,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.455632138866007,0.851530683533767
442,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.456617828255166,0.851530683533767
443,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.457246173097526,0.851530683533767
444,WP_GLYOXYLATE_METABOLISM,5,Down,0.460505899610582,0.85566974589804
445,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.463188501423749,0.856945164494088
446,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Up,0.463269749532561,0.856945164494088
447,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.465281159810646,0.858740395623675
448,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.466889214921308,0.859784826584998
449,WP_G13_SIGNALING,30,Up,0.468122936436921,0.85981149163473
450,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.468988086346216,0.85981149163473
451,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.470052506820977,0.859852146623738
452,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.474196869010721,0.863396943012057
453,WP_RAS_SIGNALING,114,Up,0.47470888186438,0.863396943012057
454,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.475210052703693,0.863396943012057
455,WP_MTHFR_DEFICIENCY,18,Down,0.476176495843013,0.863396943012057
456,WP_IL3_SIGNALING,45,Up,0.478346657139312,0.865429807324412
457,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.479636289371205,0.865864198536639
458,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Up,0.481604988493617,0.866784037957713
459,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Up,0.48224711930011,0.866784037957713
460,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.486059780414377,0.868771674550634
461,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.486277601326791,0.868771674550634
462,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.487311339199952,0.868771674550634
463,WP_CYTOSINE_METHYLATION,7,Up,0.490119722665167,0.868771674550634
464,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Up,0.492167110141673,0.868771674550634
465,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.4922647304126,0.868771674550634
466,WP_GASTRIC_CANCER_NETWORK_2,25,Up,0.49265120698325,0.868771674550634
467,WP_TYPE_II_DIABETES_MELLITUS,12,Down,0.4934292104044,0.868771674550634
468,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.495315551180323,0.868771674550634
469,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.495589955334009,0.868771674550634
470,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.495589955334009,0.868771674550634
471,WP_RETT_SYNDROME,30,Down,0.496088363827741,0.868771674550634
472,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.497042703500484,0.868771674550634
473,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.498489828892183,0.869459003881714
474,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.504313082646795,0.875904107594337
475,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.50693445654257,0.875904107594337
476,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Up,0.507628466552625,0.875904107594337
477,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.50807252308302,0.875904107594337
478,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.508743212626491,0.875904107594337
479,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.509494435774259,0.875904107594337
480,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.510347554291818,0.875904107594337
481,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.511699752839162,0.875904107594337
482,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.512705312928916,0.875904107594337
483,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.512802041173412,0.875904107594337
484,WP_15Q11Q13_COPY_NUMBER_VARIATION,29,Down,0.520646409795232,0.887465471241873
485,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Up,0.523367245173346,0.889462991936235
486,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.523974562522437,0.889462991936235
487,WP_COMPLEMENT_SYSTEM,53,Down,0.526651229086494,0.890348217302187
488,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.526654460658748,0.890348217302187
489,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.529184565441487,0.892796045990239
490,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.531908325742007,0.894709745772313
491,WP_SILDENAFIL_TREATMENT,11,Up,0.535381260324305,0.894709745772313
492,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.536245136454398,0.894709745772313
493,WP_MIRNA_BIOGENESIS,6,Up,0.53924981082333,0.894709745772313
494,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.53933980780131,0.894709745772313
495,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Down,0.540387519731188,0.894709745772313
496,WP_MALE_INFERTILITY,71,Up,0.540417635824492,0.894709745772313
497,WP_CELLULAR_PROTEOSTASIS,6,Down,0.540840388847586,0.894709745772313
498,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.54147279946802,0.894709745772313
499,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.541905281431602,0.894709745772313
500,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.545438226005724,0.894709745772313
501,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.547069743960173,0.894709745772313
502,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.547204876912006,0.894709745772313
503,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Up,0.548288250979676,0.894709745772313
504,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.549390226233529,0.894709745772313
505,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.549395582570786,0.894709745772313
506,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.549524160838384,0.894709745772313
507,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.549839807401894,0.894709745772313
508,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.552478690708302,0.896273285004079
509,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.553106087892414,0.896273285004079
510,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.554872343110106,0.896273285004079
511,WP_ALSTROM_SYNDROME,27,Down,0.555146240772224,0.896273285004079
512,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.557281173012082,0.896809417942675
513,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.56337107785201,0.896809417942675
514,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Down,0.564429581077274,0.896809417942675
515,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.564938867029112,0.896809417942675
516,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.565470017967595,0.896809417942675
517,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.565982854382566,0.896809417942675
518,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.566294260340172,0.896809417942675
519,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.566699226523577,0.896809417942675
520,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Up,0.567215579271665,0.896809417942675
521,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.567382746618901,0.896809417942675
522,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.567435777171001,0.896809417942675
523,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.5697635354496,0.898766571215908
524,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.571396137391174,0.899621781197936
525,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.575413528106726,0.902564059505569
526,WP_HIPPO_SIGNALING_REGULATION,41,Up,0.575498329125911,0.902564059505569
527,WP_NRF2ARE_REGULATION,21,Up,0.577090620193727,0.902564059505569
528,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.577876362120013,0.902564059505569
529,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.579118593937356,0.902564059505569
530,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.579829032167214,0.902564059505569
531,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.581847309305488,0.903701268125991
532,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.5827503935067,0.903701268125991
533,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.584722411137485,0.904111613258644
534,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Up,0.585717104316418,0.904111613258644
535,WP_ENERGY_METABOLISM,41,Up,0.587761834407413,0.904111613258644
536,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.588583934163351,0.904111613258644
537,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.589138686379063,0.904111613258644
538,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.589590361131092,0.904111613258644
539,WP_DOPAMINE_METABOLISM,7,Up,0.592079917292899,0.906244771366682
540,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.59331249186718,0.906449640352636
541,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.595386688914457,0.907432631937712
542,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.596155741224533,0.907432631937712
543,WP_ID_SIGNALING,11,Up,0.599318491033006,0.910375794647725
544,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.600296281561651,0.910375794647725
545,WP_NOTCH_SIGNALING_WP268,34,Up,0.601656245884446,0.910552232508896
546,WP_CREATINE_PATHWAY,2,Down,0.603634161620259,0.910552232508896
547,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.603723722645293,0.910552232508896
548,WP_IRON_METABOLISM_DISORDERS,12,Up,0.605990700971735,0.912303518798689
549,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.607926469482694,0.913550705506781
550,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.612075465274992,0.915792287912716
551,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.613055910531833,0.915792287912716
552,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.614823120496764,0.915792287912716
553,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.615673728249088,0.915792287912716
554,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.616213332705024,0.915792287912716
555,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.617365733319835,0.915792287912716
556,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.618211972578059,0.915792287912716
557,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.61876653779706,0.915792287912716
558,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.620317292286254,0.915792287912716
559,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.620847579033226,0.915792287912716
560,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.621628704522571,0.915792287912716
561,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.625377077013079,0.918072220808223
562,WP_BENZENE_METABOLISM,3,Down,0.625401924962693,0.918072220808223
563,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.630803913052549,0.923729789807825
564,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.632461448860728,0.923729789807825
565,WP_TRYPTOPHAN_METABOLISM,17,Up,0.633892303314912,0.923729789807825
566,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Up,0.635263088140504,0.923729789807825
567,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.636289117172375,0.923729789807825
568,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.638150709899745,0.923729789807825
569,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.63852978982234,0.923729789807825
570,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.638560360587188,0.923729789807825
571,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.639332981794264,0.923729789807825
572,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.643739220761453,0.927267540262861
573,WP_PURINE_METABOLISM,10,Down,0.644029455237115,0.927267540262861
574,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.645774775909987,0.928160609975156
575,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.648281228978574,0.929900821376858
576,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.650653543797663,0.929900821376858
577,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,270,Up,0.651636260453044,0.929900821376858
578,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.656430012553367,0.929900821376858
579,WP_HISTONE_MODIFICATIONS,35,Up,0.656709045824321,0.929900821376858
580,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.657328689550985,0.929900821376858
581,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.659228427592063,0.929900821376858
582,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.65968948526369,0.929900821376858
583,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.659892138546243,0.929900821376858
584,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Up,0.662516680095554,0.929900821376858
585,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.662910697041128,0.929900821376858
586,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.662995738492593,0.929900821376858
587,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.663261653461303,0.929900821376858
588,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.663886894782214,0.929900821376858
589,WP_KALLMANN_SYNDROME,11,Up,0.663892828837539,0.929900821376858
590,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.668461759202086,0.933284830489742
591,WP_TP53_NETWORK,14,Up,0.668900796868527,0.933284830489742
592,WP_FRAGILE_X_SYNDROME,83,Down,0.669702569272639,0.933284830489742
593,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.670921338358357,0.933406583719467
594,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Up,0.674996136142961,0.936130488333984
595,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.675872220555911,0.936130488333984
596,WP_SPINA_BIFIDA,10,Down,0.677656316559151,0.936130488333984
597,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.678286292448379,0.936130488333984
598,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.679668650029408,0.936130488333984
599,WP_TNFALPHA_SIGNALING,81,Up,0.679687469711584,0.936130488333984
600,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.682531362504777,0.938480623444068
601,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Up,0.685349850973011,0.939432403520947
602,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.686371504060883,0.939432403520947
603,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.687180967460976,0.939432403520947
604,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.688355889078089,0.939432403520947
605,WP_EGFEGFR_SIGNALING,138,Up,0.689886220879704,0.939432403520947
606,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.691089613886559,0.939432403520947
607,WP_BASE_EXCISION_REPAIR,29,Up,0.691194507802684,0.939432403520947
608,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.694257063748194,0.941369696024779
609,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.695658722276819,0.941369696024779
610,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.696043047969836,0.941369696024779
611,WP_OVARIAN_INFERTILITY,21,Up,0.699606078614923,0.944639958849937
612,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.703493104682651,0.94746342890169
613,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.706164875162679,0.94746342890169
614,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.706638822352329,0.94746342890169
615,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.706732803949663,0.94746342890169
616,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.707439360246595,0.94746342890169
617,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.710428245342605,0.949924315085331
618,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.71402864748219,0.95000147941133
619,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.714304369179901,0.95000147941133
620,WP_FERROPTOSIS,48,Up,0.716039495374477,0.95000147941133
621,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.71772192648146,0.95000147941133
622,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.717811505640876,0.95000147941133
623,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.718388484315524,0.95000147941133
624,WP_PHOSPHOINOSITIDES_METABOLISM,37,Down,0.718696702960772,0.95000147941133
625,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.720142434494649,0.95000147941133
626,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.72084960740787,0.95000147941133
627,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.722732248654157,0.950040392632502
628,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.725697900474722,0.950040392632502
629,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.725972759205551,0.950040392632502
630,WP_PREIMPLANTATION_EMBRYO,20,Up,0.72769498848555,0.950040392632502
631,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.728351912672786,0.950040392632502
632,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.728687752664997,0.950040392632502
633,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.728940083074392,0.950040392632502
634,WP_GLUCURONIDATION,7,Down,0.73258903434332,0.951303616215923
635,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Down,0.733921103622087,0.951303616215923
636,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.734527710168109,0.951303616215923
637,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Up,0.735407537218508,0.951303616215923
638,WP_AMINO_ACID_METABOLISM,57,Down,0.736217523094604,0.951303616215923
639,WP_MONOAMINE_GPCRS,3,Up,0.737513080944613,0.951303616215923
640,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.739055324379782,0.951303616215923
641,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.740841412466791,0.951303616215923
642,WP_AUTOPHAGY,27,Up,0.741934155591886,0.951303616215923
643,WP_CHOLESTEROL_METABOLISM,50,Down,0.742050093714021,0.951303616215923
644,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.74361746479927,0.951303616215923
645,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.743746463586994,0.951303616215923
646,WP_THERMOGENESIS,74,Up,0.74745751370182,0.952375812785524
647,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.748462730767871,0.952375812785524
648,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.751007152236256,0.952375812785524
649,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.75157942246634,0.952375812785524
650,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.753088017512234,0.952375812785524
651,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.753310001137406,0.952375812785524
652,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.754649612484957,0.952375812785524
653,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.754916077755692,0.952375812785524
654,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.754974280680888,0.952375812785524
655,WP_KININKALLIKREIN_PATHWAY,2,Up,0.757127951546988,0.953634442788191
656,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.760828066290409,0.955861098867655
657,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.761213020552787,0.955861098867655
658,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.763320652945932,0.957050970638896
659,WP_IDO_METABOLIC_PATHWAY,6,Up,0.76610934637924,0.959089849412554
660,WP_ESTROGEN_SIGNALING,21,Up,0.768628124815933,0.960785156019916
661,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.772142718363691,0.963718218835167
662,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.773705526132639,0.964210059002156
663,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.780770190923947,0.970752317046059
664,WP_NETRINUNC5B_SIGNALING,35,Up,0.781911478962134,0.970752317046059
665,WP_ALLOGRAFT_REJECTION,50,Up,0.782485201012884,0.970752317046059
666,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.786044557158424,0.973703843326876
667,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.789441793690041,0.975980461938149
668,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.790248422514768,0.975980461938149
669,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.793821804670138,0.978928234458691
670,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.799332132014363,0.982077849455071
671,WP_CILIARY_LANDSCAPE,182,Down,0.799698459978113,0.982077849455071
672,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.801759067765425,0.982077849455071
673,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.802324878611699,0.982077849455071
674,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.804853322180419,0.982077849455071
675,WP_NEPHROGENESIS,3,Down,0.805175696581656,0.982077849455071
676,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.805323820642847,0.982077849455071
677,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.808163792556268,0.982077849455071
678,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.808918031180858,0.982077849455071
679,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.812039933758868,0.982077849455071
680,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.812398985851006,0.982077849455071
681,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.812400181856794,0.982077849455071
682,WP_HIPPOYAP_SIGNALING,15,Up,0.812459927318793,0.982077849455071
683,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.813041419609471,0.982077849455071
684,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.814662614278898,0.982597451432881
685,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.818153544547862,0.983490204667523
686,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.819023397436898,0.983490204667523
687,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.819734357160025,0.983490204667523
688,WP_IL11_SIGNALING,40,Up,0.820359788059482,0.983490204667523
689,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Down,0.823946906083259,0.983490204667523
690,WP_AEROBIC_GLYCOLYSIS,10,Down,0.824602201538825,0.983490204667523
691,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.824602201538825,0.983490204667523
692,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.824939662581728,0.983490204667523
693,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.826781501165948,0.984263691864224
694,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.828540373243055,0.984882010412764
695,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.831814647619131,0.984882010412764
696,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.833338609571289,0.984882010412764
697,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.834377689118483,0.984882010412764
698,WP_CORI_CYCLE,11,Down,0.836727894316035,0.984882010412764
699,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.839477179894678,0.984882010412764
700,WP_NEUROINFLAMMATION,10,Up,0.840027330409932,0.984882010412764
701,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.841069179533098,0.984882010412764
702,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.841626519835689,0.984882010412764
703,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.841993301140927,0.984882010412764
704,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.842050691907449,0.984882010412764
705,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.842145507547138,0.984882010412764
706,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.845209953976003,0.984882010412764
707,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.84601515726885,0.984882010412764
708,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.849157137279048,0.984882010412764
709,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.849700724408605,0.984882010412764
710,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.849807234916979,0.984882010412764
711,WP_G_PROTEIN_SIGNALING,62,Up,0.849878969715247,0.984882010412764
712,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.850003738379415,0.984882010412764
713,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.851430172472964,0.984882010412764
714,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.853577761780568,0.984882010412764
715,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.854819020841827,0.984882010412764
716,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Up,0.855489911384471,0.984882010412764
717,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.855952001776911,0.984882010412764
718,WP_IL4_SIGNALING,50,Up,0.861575283818668,0.988018119790049
719,WP_FOLATE_METABOLISM,36,Down,0.861942687557354,0.988018119790049
720,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.862270359089497,0.988018119790049
721,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.863824341913248,0.988425911343175
722,WP_PROLACTIN_SIGNALING,70,Up,0.868178617858543,0.992032354201244
723,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.871716680935165,0.993296898397648
724,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.8724237549681,0.993296898397648
725,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Up,0.877559682465519,0.993296898397648
726,WP_DNA_MISMATCH_REPAIR,21,Up,0.878783684435875,0.993296898397648
727,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.88318187123068,0.993296898397648
728,WP_ATR_SIGNALING,10,Up,0.883600198687996,0.993296898397648
729,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.884272696983888,0.993296898397648
730,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.884575366544474,0.993296898397648
731,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.886302571395486,0.993296898397648
732,WP_AXON_GUIDANCE,33,Down,0.886397145718792,0.993296898397648
733,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.891804652273032,0.993296898397648
734,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.892879548790567,0.993296898397648
735,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.892971466950531,0.993296898397648
736,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.895523245391543,0.993296898397648
737,WP_ONECARBON_METABOLISM,22,Down,0.895932181391901,0.993296898397648
738,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.897116945430707,0.993296898397648
739,WP_FOXP3_IN_COVID19,9,Down,0.897948943811281,0.993296898397648
740,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.898210244224701,0.993296898397648
741,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.905444255629354,0.993296898397648
742,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.9060093324612,0.993296898397648
743,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.9077671715592,0.993296898397648
744,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.90858270065645,0.993296898397648
745,WP_RANKLRANK_SIGNALING,47,Down,0.908667789901887,0.993296898397648
746,WP_ASPIRIN_AND_MIRNAS,8,Down,0.909410714916305,0.993296898397648
747,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Up,0.90955976262811,0.993296898397648
748,WP_ARYLAMINE_METABOLISM,1,Up,0.909619503095439,0.993296898397648
749,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Up,0.909837943721205,0.993296898397648
750,WP_BARDETBIEDL_SYNDROME,62,Down,0.910680637023593,0.993296898397648
751,WP_MAPK_CASCADE,30,Down,0.913034050511252,0.993296898397648
752,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,14,Up,0.913057557211062,0.993296898397648
753,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.913890306660864,0.993296898397648
754,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.915271051531241,0.993296898397648
755,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Down,0.915440189163283,0.993296898397648
756,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.915572610399334,0.993296898397648
757,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.915713601321777,0.993296898397648
758,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.919232247662065,0.993296898397648
759,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.920108536418643,0.993296898397648
760,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.920235661587323,0.993296898397648
761,WP_ERBB_SIGNALING,68,Up,0.920939853940763,0.993296898397648
762,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.922033021291076,0.993296898397648
763,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.922116542696394,0.993296898397648
764,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.922233922963388,0.993296898397648
765,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.924847643137158,0.993296898397648
766,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.924945851182586,0.993296898397648
767,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.926038231875203,0.993296898397648
768,WP_CHOLESTASIS,9,Down,0.926505698413572,0.993296898397648
769,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Up,0.92793287013209,0.993296898397648
770,WP_P38_MAPK_SIGNALING,31,Up,0.928896850170689,0.993296898397648
771,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.930342283247354,0.993296898397648
772,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.932478632318067,0.993296898397648
773,WP_LEPTIN_SIGNALING,70,Up,0.932989412422095,0.993296898397648
774,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Up,0.933074728117814,0.993296898397648
775,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.933097086373548,0.993296898397648
776,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.936643065908066,0.993877675900759
777,WP_IL9_SIGNALING,15,Down,0.939239511704649,0.993877675900759
778,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.939998392907994,0.993877675900759
779,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.942140258518346,0.993877675900759
780,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.943084880591516,0.993877675900759
781,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.944643298245086,0.993877675900759
782,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Up,0.946173680400185,0.993877675900759
783,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.946269543055867,0.993877675900759
784,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.946937874342097,0.993877675900759
785,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Down,0.947591268328441,0.993877675900759
786,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.948677136094721,0.993877675900759
787,WP_TRANSSULFURATION_PATHWAY,8,Up,0.949624991468006,0.993877675900759
788,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.950477408057363,0.993877675900759
789,WP_PPARALPHA_PATHWAY,16,Down,0.951755028907099,0.993877675900759
790,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.95274435749787,0.993877675900759
791,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.952917868651516,0.993877675900759
792,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.955712141019881,0.995533480229043
793,WP_VALPROIC_ACID_PATHWAY,8,Down,0.95822703841164,0.995685451576022
794,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.958739017071684,0.995685451576022
795,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Up,0.959478707882349,0.995685451576022
796,WP_VITAMIN_D_METABOLISM,6,Up,0.960989209047366,0.996000122442308
797,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.969342474830392,0.999156216097097
798,WP_IL6_SIGNALING,39,Up,0.970880933784874,0.999156216097097
799,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.971019385540979,0.999156216097097
800,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.971115040248762,0.999156216097097
801,WP_B_CELL_RECEPTOR_SIGNALING,87,Up,0.97140616702412,0.999156216097097
802,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.97426243795318,0.999156216097097
803,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.977209982587722,0.999156216097097
804,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Up,0.978186188823102,0.999156216097097
805,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.978224242911007,0.999156216097097
806,WP_IL1_SIGNALING,51,Down,0.978414027972428,0.999156216097097
807,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.978688384242474,0.999156216097097
808,WP_MRNA_PROCESSING,124,Up,0.978816792638884,0.999156216097097
809,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.982473218089554,0.999156216097097
810,WP_GPCRS_OTHER,13,Up,0.982806768917384,0.999156216097097
811,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.984126882257395,0.999156216097097
812,WP_HYPERTROPHY_MODEL,13,Up,0.984476308614666,0.999156216097097
813,WP_GLIOBLASTOMA_SIGNALING,65,Up,0.984623034772048,0.999156216097097
814,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.986924502350724,0.999575552327105
815,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.988960020637546,0.999575552327105
816,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.990447352766485,0.999575552327105
817,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.99239686721907,0.999575552327105
818,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.992816580426232,0.999575552327105
819,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.993456209272999,0.999575552327105
820,WP_IL18_SIGNALING,190,Down,0.994418087345767,0.999575552327105
821,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.994787115743151,0.999575552327105
822,WP_NEPHROTIC_SYNDROME,26,Up,0.996828538770448,0.999575552327105
823,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,164,Up,0.998252541824986,0.999575552327105
824,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.998971303705416,0.999575552327105
825,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.999575552327105,0.999575552327105
